Skip to main content
PRCT
NASDAQ Industrial Applications And Services

PROCEPT 10-Q: Q3 Revenue $98.3M Misses, Cash Burn Widens, Two Lawsuits Disclosed

Arie Shkolnikov · Analysis by Wiseek AI
More coverage: Medical Device Stocks · Healthcare
Sentiment info
Negative
Importance info
7
Price
$18.06
Mkt Cap
$1.241B
52W Low
$16.665
52W High
$38.11
52W Position info
8.4% above low
Off High info
53% below high
Rel. Volume info
2.3× avg
Market data snapshot near publication time

PRCT is trading near its 52-week low of $16.665 (8.4% above the low) on elevated volume (2.3× avg).

Summary

PROCEPT's Q3 10-Q confirms $98.3 million of revenue (up 18% but short of consensus) and a $26.5 million net loss, while disclosing a securities class action and a derivative suit plus a nine-month operating cash burn of $66.4 million.


Key Events · Earnings and Guidance · PRCT

  • Q3 Revenue Grows 18% but Misses

    Revenue of $98.3 million rose from $83.3 million a year earlier, with U.S. revenue of $85.8 million and handpieces/consumables up 22% to $60.8 million.

  • Losses and Cash Burn Widen

    Net loss was $26.5 million versus $21.4 million, and nine-month operating cash use reached $66.4 million against $38.7 million a year earlier.

  • Two Lawsuits Disclosed

    A putative securities class action filed July 24, 2026 and a derivative suit filed September 15, 2026 allege misleading statements on handpiece sales, procedure volumes and discounting; loss cannot be estimated.

  • Cash Position and Runway

    Cash and cash equivalents were $218.4 million at September 30, 2026, down from $286.5 million at December 31, 2025; management says this funds operations at least twelve months.


Analysis · PRCT · Industrial Applications And Services

The headline numbers were already out via the morning 8-K, but the full 10-Q adds what the press release did not: two securities-related lawsuits now on the books and a materially faster cash burn. Nine-month operating cash use jumped to $66.4 million from $38.7 million a year earlier, and cash fell to $218.4 million from $286.5 million at year-end. At that pace the balance sheet still funds operations past twelve months, but the combination of a revenue miss, widening losses and fresh litigation raises the cost of any future capital raise.

How filings like this one have moved

In the 30 days to Nov 17, 2026, 38% of the 3791 measured filings Wiseek scored 7 moved their stock by 5% or more by the next session's close. The median move was 0.00%. These are measured outcomes after filings of this importance, not a forecast for this one.

Measured one observation per ticker per day, after exclusions. Current figures: Filing Impact Tracker · open dataset

At the time of this filing, PRCT was trading at $18.06 on NASDAQ in the Industrial Applications And Services sector, with a market capitalization of approximately $1.2B. The 52-week trading range was $16.67 to $38.11. This filing was assessed with negative market sentiment and an importance score of 7 out of 10.

View Main SEC Filing

Price Chart

Share this article

Copied!

PRCT - Latest Insights

PRCT
Nov 04, 2026, 4:06 PM EST
Source: Reuters
Importance Score:
8
Price at Filing: $20.11
Real-time Price: $25.14 info
Change: +$5.03 (+25%) info
Market Cap: $1.449B info
PRCT
Aug 04, 2026, 4:12 PM EDT
Filing Type: 8-K
Importance Score:
7
Price at Filing: $17.57
Real-time Price: $25.14 info
Change: +$7.57 (+43%) info
Market Cap: $1.449B info
PRCT
Aug 04, 2026, 6:36 AM EDT
Source: PR Newswire
Importance Score:
8
Price at Filing: $18.42
Real-time Price: $25.14 info
Change: +$6.72 (+36%) info
Market Cap: $1.449B info
PRCT
Aug 03, 2026, 7:33 AM EDT
Source: Wiseek News
Importance Score:
7
Price at Filing: $18.62
Real-time Price: $25.14 info
Change: +$6.52 (+35%) info
Market Cap: $1.449B info
PRCT
May 28, 2026, 8:00 AM EDT
Source: GlobeNewswire
Importance Score:
8
Price at Filing: $26.52
Real-time Price: $25.14 info
Change: -$1.38 (-5%) info
Market Cap: $1.449B info